This study is a randomized, controlled trial of 12-step facilitation, an individual therapy designed to help patients become actively engaged in 12-step programs (such as Double Trouble in Recovery and Alcoholics Anonymous).Patients will receive standard care in the Dual Diagnosis Program or standard care plus 12-step facilitation therapy (TSF). During the study, patients must be enrolled in the D

This study will investigate how brain activity may relate to behaviors in people who are experiencing psychosis. The study uses EEG and fMRI to examine brain function and structure; cognitive testing; and DNA collection to explore genetic influences on brain activity and behavior. Participants will be compensated for their time. Please call 272-9552 or email PsychResearch@salud.unm.edu for more in

This study will examine how alcohol effects brain development in adolescents.Specifically, this study will look at brain structure and brain activity in adolescents who have drank alcohol and adolescents who have not. The study takes approximately 1 to 2 visits and requires 1 follow up visit after a year. Participants will be compensated for their time. Please call 272-9456 or email PsychResearch@

This research study will evaluate the differences in magnetic resonance images (MRI) data collected at different sites across the country and will work to develop methods to decrease those differences. Participants will undergo a series of brain scans throughout the course of this study. Participants will be compensated for their time. Please call 272-9552 or email PsychResearch@salud.unm.edu for

This is a randomized trial to determine if caffeine reduction education in women with Overactive Bladder Symptoms (OAB) improves bladder symptoms including urinary frequency, incontinence and urinary urgency.

This Center for Biomedical Research Excellence (COBRE) will examine the neural mechanisms of schizophrenia by integrating multiple neuroimaging methods with psychiatric, neuropsychological and genetic testing. Participants will receive multiple brain scans throughout the course of this study. Participants will be compensated for their time. Please call 272-9544 or email PsychResearch@salud.unm.edu

This study will investigate the effectiveness of Risperdal CONSTA versus certain oral atypical antipsychotics. Patients will have a 50-50% chance of being placed on Risperdal CONSTA or on one of six other atypicals. Patients are seen every 2 weeks and receive case-management support. The study will last approximately 30 months. Participants will be compensated for their time. Please call 272-9544

This study seeks participants who are 50-75 years old, have Type 2 Diabetes and are on insulin therapy. The study will include five overnight hospital stays that will explore the effects of alcohol on overnight glucose regulation. Qualified participants will be compensated for their time. Please call Paul Hicks at 272-4338 for more details

This study seeks participants who are 50-75 years old, have Type 2 Diabetes and are on insulin therapy. The study will include five overnight hospital stays that will explore the effects of alcohol on overnight glucose regulation. Qualified participants will be compensated for their time. Please call Paul Hicks at 272-4338 for more details

This study will evaluate and treat individuals in the early stages of a psychotic illness. All patients will receive a thorough diagnostic evaluation. Those deemed appropriate for the longitudinal piece of the study will be seen at the clinic for weekly to monthly appointments. Subjects followed in the longitudinal part of the study will receive ongoing medication and case-management services, as

This study will assess the tolerability and efficacy of ziprasidone dose escalation.Patients will be treated for eight weeks and will be assigned to either the ziprasidone high-dose treatment group (320 mg) or the ziprasidone standard treatment group (160 mg). Participants will be compensated for their time. Please call 272-9544 or email PsychResearch@salud.unm.edu for more information.

The purpose of this research study is to investigate how the brain responds to sensory stimuli and where in the brain these responses occur in people with different medical conditions. Specifically this study will look at brain activity in people who have been diagnosed and treated for substance abuse (either alcohol or drugs) and/or schizophrenia, and people who have not been diagnosed with eithe

This study will help determine if there is a difference in the effect on sleep between two treatments used for insomnia in stable patients with schizophrenia. Patients will be randomly assigned to receive either quetiapine or zolpidem and will be followed for one month. Patients will be assessed using an actigraph device and will be seen weekly. Participants will be compensated for their time. Ple

Do you have Type 1 Diabetes? You may qualify to participate in an important research study. To qualify you must have type 1 diabetes for more than one year, be 18 - 70 years old, and be willing to participate in 8 clinic visits. You will be paid $50 for each clinic visit. If interested, please contact Elizabeth at 272-5454 or by email at evaldez@salud.unm.edu